ONEMEDNET CORPORATION Business Acquisition, Transaction Costs
ONEMEDNET CORPORATION (ONMD) had Business Acquisition, Transaction Costs of $900.00 thousand as of 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts · last filed 2025-04-15
- 2024-12-31: Business Acquisition, Transaction Costs $900.00K.
- 2023-11-07: Business Acquisition, Transaction Costs $900.00K.
| Period end | Business Acquisition, Transaction Costs |
|---|---|
| 2024-12-31 | $900.00K 10-K · filed 2025-04-15 |
| 2023-11-07 | $900.00K 10-K/A · filed 2024-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |